ORMP
ORAMED PHARMACEUTICALS INC.
$3.87
+1.84%
$158.4M
No data for this timeframe.
Vol
Market Cap$158.4M
Cap SizeMicro Cap
Inst. Holders24 funds
Inst. Value$6.0M
Inst. Activity0 buys / 3 sells
Recent Activity
Mar 30, 2026
Insider
Kidron Miriam surrendered for taxes 435,084 shares
Chief Scientific Officer @ $3.31 ($1.4M)
Mar 30, 2026
Insider
KIDRON NADAV surrendered for taxes 44,818 shares
President and CEO @ $3.31 ($148.3K)
Mar 25, 2026
earnings_calendar
ORMP Q4 2025 Earnings After Market Close — 2026-03-25
Mar 17, 2026
Insider
Gabay Avraham was granted 95,889 shares
Chief Financial Officer
Inst.
WEALTH ENHANCEMENT ADVISORY SERVICES, — TRIM
13,499 shares ($46.2K)
Inst.
FMR LLC — TRIM
200 shares ($680.00)
Price Targets
Historical data — last covering-analyst action Sep 2024. No current recommendation available.
$6.25 (Sep 2024)
Current $3.87
Low $6.25
Median $6.25
High $6.25
1 analysts
$6.25
$6.25
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 9, 2024 | HC Wainwright & Co. | REITERATE | Neutral |
| May 20, 2024 | HC Wainwright & Co. | REITERATE | Neutral |
| May 17, 2023 | Canaccord Genuity | MAINTAIN | Hold → Hold |
| Jan 17, 2023 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
| Jan 12, 2023 | Canaccord Genuity | DOWNGRADE | Buy → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.15 | $0.15 — $0.15 | -52% YoY | 1 |
| Next Q | $0.19 | $0.19 — $0.19 | -83% YoY | 1 |
| Current FY | $0.71 | $0.71 — $0.71 | -53% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MARSHALL WACE, LLP | $882.7K | — |
| Rathbones Group PLC | $792.3K | — |
| DIMENSIONAL FUND ADVISORS LP | $537.7K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $535.8K | DOUBLED |
| RENAISSANCE TECHNOLOGIES LLC | $502.2K | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 30, 2026 | Kidron Miriam | F | $1.4M |
| Mar 30, 2026 | KIDRON NADAV | F | $148.3K |
| Mar 17, 2026 | Gabay Avraham | A | $0.00 |
| Mar 17, 2026 | KIDRON NADAV | A | $0.00 |
| Mar 17, 2026 | Hexter Joshua | A | $0.00 |
24 institutional holders with $6.0M total value (1,800,093 shares) as of 2026-Q1. Top holders: MARSHALL, Rathbones, DIMENSIONAL. Net selling activity: 3 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MARSHALL WACE, LLP | 259,611 | $882.7K | 14.6% | — |
| 2 | Rathbones Group PLC | 233,018 | $792.3K | 13.1% | — |
| 3 | DIMENSIONAL FUND ADVISORS LP | 158,209 | $537.7K | 8.9% | DOUBLED +143.8% |
| 4 | WELLS FARGO & COMPANY/MN | 157,586 | $535.8K | 8.9% | DOUBLED +519.9% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 147,700 | $502.2K | 8.3% | TRIM -38.1% |
| 6 | BANK OF AMERICA CORP /DE/ | 146,152 | $496.9K | 8.2% | — |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 136,218 | $463.1K | 7.7% | — |
| 8 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 116,363 | $395.6K | 6.6% | — |
| 9 | CITADEL ADVISORS LLC | 98,629 | $335.3K | 5.6% | ADD +27.9% |
| 10 | BlackRock, Inc. | 92,192 | $313.5K | 5.2% | ADD +28.2% |
| 11 | Hudson Bay Capital Management LP | 51,670 | $175.7K | 2.9% | — |
| 12 | Connor, Clark & Lunn Investment Management Ltd. | 50,207 | $170.7K | 2.8% | ADD +54.9% |
| 13 | Point72 Asset Management, L.P. | 26,052 | $88.6K | 1.5% | — |
| 14 | PNC FINANCIAL SERVICES GROUP, INC. | 21,200 | $72.1K | 1.2% | — |
| 15 | BARCLAYS PLC | 19,966 | $67.9K | 1.1% | — |
| 16 | OMERS ADMINISTRATION Corp | 18,400 | $62.6K | 1.0% | — |
| 17 | MORGAN STANLEY | 14,052 | $47.8K | 0.8% | TRIM -47.3% |
| 18 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 13,499 | $46.2K | 0.8% | TRIM -26.2% |
| 19 | CITIGROUP INC | 8,989 | $30.6K | 0.5% | — |
| 20 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1,575 | $5.4K | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | TRIM | 18,299 | 13,499 | -26.2% | $46.2K | 2026-Q1 |
| FMR LLC | TRIM | 500 | 200 | -60.0% | $680.00 | 2026-Q1 |
| HRT FINANCIAL LP | TRIM | 46,091 | 27,498 | -40.3% | $93.00 | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 28,243 | 43,735 | +54.9% | $124.6K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 20,986 | 130,086 | +519.9% | $343.4K | 2025-Q3 |
| CITADEL ADVISORS LLC | ADD | 87,316 | 111,707 | +27.9% | $294.9K | 2025-Q3 |
| BlackRock, Inc. | ADD | 85,570 | 109,733 | +28.2% | $289.7K | 2025-Q3 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 60,449 | 28,243 | -53.3% | $74.6K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 32,095 | 16,924 | -47.3% | $44.7K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 12,779 | 357 | -97.2% | $943.00 | 2025-Q3 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 87,136 | 60,449 | -30.6% | $136.0K | 2025-Q2 |
| ROYAL BANK OF CANADA | TRIM | 86,988 | 47,591 | -45.3% | $107.0K | 2025-Q2 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | ADD | 13,799 | 18,799 | +36.2% | $41.0K | 2025-Q2 |
| UBS Group AG | TRIM | 35,583 | 12,779 | -64.1% | $28.8K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 110,378 | 64,418 | -41.6% | $137.9K | 2025-Q1 |
| UBS Group AG | TRIM | 112,981 | 35,583 | -68.5% | $76.1K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 245,300 | 151,808 | -38.1% | $367.4K | 2024-Q4 |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | 48,805 | 118,995 | +143.8% | $288.0K | 2024-Q4 |
| UBS Group AG | DOUBLED | 28,184 | 112,981 | +300.9% | $273.4K | 2024-Q4 |
| ROYAL BANK OF CANADA | DOUBLED | 4,227 | 85,525 | +1923.3% | $207.0K | 2024-Q4 |
| DIMENSIONAL FUND ADVISORS LP | ADD | 31,470 | 48,805 | +55.1% | $119.1K | 2024-Q3 |
| GROUP ONE TRADING LLC | NEAR_EXIT | 9,188 | 100 | -98.9% | $244.00 | 2024-Q3 |
4 unique insiders with 7 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Kidron Miriam | Chief Scientific Officer | TAX W/H | 435,084 | $3.31 | $1.4M |
| Mar 30, 2026 | KIDRON NADAV | President and CEO | TAX W/H | 44,818 | $3.31 | $148.3K |
| Mar 17, 2026 | Gabay Avraham | Chief Financial Officer | AWARD | 95,889 | — | — |
| Mar 17, 2026 | KIDRON NADAV | President and CEO | AWARD | 167,005 | — | — |
| Mar 17, 2026 | Hexter Joshua | COO & CBO | AWARD | 95,889 | — | — |
| Mar 17, 2026 | Kidron Miriam | Chief Scientific Officer | AWARD | 119,558 | — | — |
| Mar 12, 2026 | KIDRON NADAV | President and CEO | GIFT | 100,000 | — | — |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Sep 2024): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Sep 2024. No current recommendation available.
$6.25 mean target (Sep 2024)
$6.25 Low
$6.25 High
| Metric | Value |
|---|---|
| Current Price | $3.87 |
| Target Low | $6.25 |
| Target Mean | $6.25 |
| Target Median | $6.25 |
| Target High | $6.25 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.15 | $0.15 | $0.15 | -51.6% | — | — | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$0.19 | $0.19 | $0.19 | -83.2% | — | — | $0.0B | 0.0% | 1 |
| Current FY 2026-12-31 |
$0.71 | $0.71 | $0.71 | -52.7% | — | 0↑ 1↓ | $0.0B | -100.0% | 1 |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.000 | |
| 7d ago | $0.000 | |
| 30d ago | $0.000 | |
| 60d ago | $0.000 | |
| 90d ago | $0.000 |
7 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 7 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Sep 9, 2024 | HC Wainwright & Co. | REITERATE | — | Neutral |
| May 20, 2024 | HC Wainwright & Co. | REITERATE | — | Neutral |
| May 17, 2023 | Canaccord Genuity | MAINTAIN | Hold | Hold |
| Jan 17, 2023 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jan 12, 2023 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| May 16, 2022 | Aegis Capital | MAINTAIN | — | Buy |
| Feb 18, 2022 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Nov 30, 2021 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Nov 29, 2021 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Nov 2, 2021 | Aegis Capital | MAINTAIN | — | Buy |
| Jul 29, 2021 | Canaccord Genuity | MAINTAIN | — | Buy |
| Jun 8, 2021 | Aegis Capital | MAINTAIN | — | Buy |
| Apr 20, 2021 | Canaccord Genuity | INITIATE | — | Buy |
| Feb 9, 2021 | National Securities Corporation | INITIATE | — | Buy |
| Jan 27, 2021 | Aegis Capital | MAINTAIN | — | Buy |
| Jul 13, 2020 | HC Wainwright & Co. | REITERATE | — | Buy |
| Jun 22, 2020 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Sep 11, 2019 | Ladenburg Thalmann | INITIATE | — | Buy |
| Nov 19, 2015 | FBR Capital | INITIATE | — | Outperform |
| Oct 1, 2015 | HC Wainwright & Co. | INITIATE | — | Buy |
| Dec 4, 2013 | Aegis Capital | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2025 | 0 | 0 | 3 | 1 | 2 | 0% | |
| May 1, 2025 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2025 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2025 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Mar 25, 2026
earnings_calendar
ORMP Q4 2025 Earnings After Market Close — 2026-03-25